R. Martinez-Hague

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules

B. Jakobsen, J. Dukes, J. Harper, 2018, PloS one.

Engineered affinity-enhanced immune-mobilising monoclonal T cell receptors (ImmTAVs) for HIV cure

B. Jakobsen, J. Frater, L. Dorrell, 2017 .